Owlstone Medical secures $6.5 million to support development of breath-based diagnostics for infectious disease Post author: Post published:April 25, 2024 Post category:uncategorized Funding represents the first time the foundation has taken an equity position in a breath diagnostics company. You Might Also Like Two kiwi fruit every day safe and can replace vitamin C supplementation November 27, 2023 Can drones delivering defibrillators outpace ambulances in saving lives during cardiac arrests? December 4, 2023 Toxic gas that sterilizes medical devices prompts safety rule update February 29, 2024
Can drones delivering defibrillators outpace ambulances in saving lives during cardiac arrests? December 4, 2023